Search

Showing "11155" results for ""

South Africa: Delayed drug registrations hard to swallow

Pressure growing on wealthy nations for clear signal on long-term funds for HIV

HIV-positive boys have reduced bone density

Rates of new HIV diagnoses amongst US gay men 44 times greater than those in other populations

Preventing unintended pregnancies in women living with HIV in resource-poor settings

Visa refusal shines spotlight on China's HIV travel ban

HIV biggest cause of adolescent death and hospitalisation in Zimbabwe

Genital ulcers frequently associated with HIV shedding in men

High prevalence of drug-resistant TB amongst HIV patients in South Africa

Over a third of TB cases in UK prisons are drug-resistant

'Test and treat' prevention approach may not require universal treatment to succeed

Weight gain after starting ART predicts survival

Drug-resistant TB now at record levels, says WHO

Aciclovir shows lower efficacy outside US in global trial

Obese patients in US have poorer CD4 cell gains after starting HIV treatment

Efavirenz, Kaletra and boosted atazanavir reduce levels of key anti-malaria drug

Integrating TB and HIV services: lessons from the field

Acne drug prevents HIV activation from latently infected cells

Receive the latest HIV research and conference news

Showing "11155" results for ""

South Africa: Delayed drug registrations hard to swallow

Pressure growing on wealthy nations for clear signal on long-term funds for HIV

HIV-positive boys have reduced bone density

Rates of new HIV diagnoses amongst US gay men 44 times greater than those in other populations

Preventing unintended pregnancies in women living with HIV in resource-poor settings

Visa refusal shines spotlight on China's HIV travel ban

HIV biggest cause of adolescent death and hospitalisation in Zimbabwe

Genital ulcers frequently associated with HIV shedding in men

High prevalence of drug-resistant TB amongst HIV patients in South Africa

Over a third of TB cases in UK prisons are drug-resistant

'Test and treat' prevention approach may not require universal treatment to succeed

Weight gain after starting ART predicts survival

Drug-resistant TB now at record levels, says WHO

Aciclovir shows lower efficacy outside US in global trial

Obese patients in US have poorer CD4 cell gains after starting HIV treatment

Efavirenz, Kaletra and boosted atazanavir reduce levels of key anti-malaria drug

Integrating TB and HIV services: lessons from the field

Acne drug prevents HIV activation from latently infected cells

Receive the latest HIV research and conference news